PhaseBio Pharmaceuticals, Inc. (2K4.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 10:16AM CEST. Market open.
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 4.40M |
| Enterprise Value | 2.02M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.17 |
| Price/Book (mrq) | 25.76 |
| Enterprise Value/Revenue | 2.47 |
| Enterprise Value/EBITDA | -0.02 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.08 |
| 52-Week Change 3 | -97.91% |
| S&P500 52-Week Change 3 | 22.43% |
| 52 Week High 3 | 3.3000 |
| 52 Week Low 3 | 0.0530 |
| 50-Day Moving Average 3 | 0.4595 |
| 200-Day Moving Average 3 | 0.8515 |
Share Statistics
| Avg Vol (3 month) 3 | 3.82k |
| Avg Vol (10 day) 3 | 18k |
| Shares Outstanding 5 | 49.86M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 46.21M |
| % Held by Insiders 1 | 0.18% |
| % Held by Institutions 1 | 4.09% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | N/A |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2021 |
| Most Recent Quarter (mrq) | Jun 30, 2022 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -12,169.23% |
Management Effectiveness
| Return on Assets (ttm) | -106.07% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 818k |
| Revenue Per Share (ttm) | 0.02 |
| Quarterly Revenue Growth (yoy) | -98.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -102.26M |
| Net Income Avi to Common (ttm) | -102.84M |
| Diluted EPS (ttm) | -2.2620 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.8M |
| Total Cash Per Share (mrq) | 0.16 |
| Total Debt (mrq) | 5.37M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.47 |
| Book Value Per Share (mrq) | -2.36 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -59.42M |
| Levered Free Cash Flow (ttm) | -33.68M |
© 2024 Yahoo. All rights reserved.